Chemcon Speciality Chemicals Limited (CHEMCON) Fair Value & Analysis
Basic Materials · IN · Market cap ₹7.0B
Fair value as of: Jun 29, 2026
Analysis
Chemcon Speciality Chemicals Limited (CHEMCON) currently trades at ₹189.10, while our model-based Fair Value estimate is ₹109.52 — implying the stock looks roughly 42.1% overvalued today. We read business quality at 97/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Chemcon Speciality Chemicals Limited engages in the manufacture and sale of specialty chemicals for pharmaceutical, agro-chemical, textile, personal care, construction, automotive, electronics, silanes, and oilfield chemicals industries in India and internationally. The company offers oilfield chemicals, including calcium bromide liquid, calcium bromide powder, sodium bromide solution, and zinc bromide solution; pharmaceutical chemicals, such as hexamethyl disilazane, trimethyl chlorosilane, hexamethyl disiloxane, bromobenzene, dibromomethane, and chloromethyl isopropyl carbonate; silanes comprising hexamethyl disilazane, trimethyl chlorosilane, and hexamethyl disiloxane; agro chemicals, including bromobenzene, ammonium chloride, and dibromomethane; and fragrance chemicals. It also provides contract development and manufacturing services. The company was incorporated in 1988 and is based in Vadodara, India.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Chemcon Speciality Chemicals Limited (CHEMCON) undervalued?
What is the fair value of CHEMCON?
What is the quality score of CHEMCON?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.